OpGen, Inc. (LON:0A8L)
London flag London · Delayed Price · Currency is GBP · Price in USD
22.00
-5.00 (-18.52%)
At close: Feb 6, 2026

OpGen Company Description

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.

The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits.

It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services.

In addition, the company offers listing sponsorship and consultancy services. OpGen, Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.

OpGen, Inc.
CountryUnited States
Founded2001
IndustrySecurity and Commodity Brokers, Dealers, Exchanges, and Services
Employees1
CEOChristian-Laurent Bonte

Contact Details

Address:
23219 Stringtown Road
Clarksburg, Maryland 20871
United States
Phone240 813 1260
Websiteopgen.com

Stock Details

Ticker Symbol0A8L
ExchangeLondon Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS68373L5057
SIC Code6200

Key Executives

NamePosition
Christian-Laurent Benoit BonteChief Executive Officer
Mohd Azham bin AzudinChief Operating Officer
David CaplonCorporate Controller
Syed Johan Bin Syed MohdChief Technology Officer
Rou Yee TanCompany Secretary